Abstracts and Awards - BCVS Scientific Sessions 2022

BCVS 2022 Abstract Categories

NEW: Abstract submission has been extended until March 23, 2022 at 6:00 p.m. CDT

  • Cardiac Regeneration, Stem Cells and Tissue Engineering
  • Cardio-immunology and Inflammation
  • Cardio-oncology
  • Cell Death Mechanisms, Apoptosis, Necrosis and Autophagy
  • Clinical/Translational Research
  • COVID 19 in the Cardiovascular System
  • Excitation-Contraction Coupling and Ion Channels and Arrhythmias
  • Genetics and Genomics of Cardiovascular Disease
  • Human Cellular Models of Disease
  • NEW: Inflammation, Thrombosis and Vascular Biology
  • Mechanisms of Cardiac Remodeling, Hypertrophy and Failure
  • NEW: Mechanisms of Heart Failure Preserved Ejection Fraction
  • Mechanisms of Myocardial Fibrosis
  • Mitochondria and Metabolism
  • Myocardial Ischemia, Oxidative Stress, and Cardioprotection
  • RNA and Cellular Regulation
  • Sarcomeric Function and Contractility
  • Signal Transduction Pathways
  • Systems Approach to Cardiovascular Biology
  • Transcriptional and Epigenetic Regulation of Gene Expression

Download a PDF of the 2022 Abstract Categories


Important Message to Abstract Submitters

The AHA has moved to a single sign-on process for submitting abstracts and disclosures through our website, Professional Heart Daily.

  • Abstract submitters must have a username and password on Professional Heart Daily to complete their abstract submission when submitting to any AHA scientific meeting.

  • If you do not remember your Professional Heart Daily login information or need to update your personal profile, do not create a new account. Please reach out to AHA Customer Service for assistance:

    AHA Customer Service
    (888) 242-2453 (Inside U.S.)
    (214) 570-5935 (Outside U.S.)
    Email: professional.help@heart.org

    Hours of Operation:
    Monday-Friday, 8 a.m. – 5 p.m. CT

  • The AHA is now required to collect financial disclosures from all abstract submitting authors and co-authors.
    • As the submitting author, please be prepared to provide all co-author emails.
    • Co-authors without a complete disclosure will receive separate correspondence to submit this information.